Correlation Between Cue Biopharma and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Enliven Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Enliven Therapeutics.
Diversification Opportunities for Cue Biopharma and Enliven Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Cue and Enliven is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Enliven Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Enliven Therapeutics. In addition to that, Cue Biopharma is 2.55 times more volatile than Enliven Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.18 per unit of volatility. If you would invest 2,763 in Enliven Therapeutics on September 2, 2024 and sell it today you would lose (325.00) from holding Enliven Therapeutics or give up 11.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Enliven Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Enliven Therapeutics |
Cue Biopharma and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Enliven Therapeutics
The main advantage of trading using opposite Cue Biopharma and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |